Manufacturer record
SVR Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by SVR Healthcare (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SNT-250038, Calcium Carbonate with Vit. D3 Tablets IP (exp Jan 2028). DTL-Baddi (state lab) found it not of standard quality: The sample does not conforms to claim as per IP 2022 in respect to the test of Dissolution of calcium and Assay of Vit.D3 Claim 250 i.u. Listed in the August 2026 alert.
Records by type
5 records linked to SVR Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium Carbonate with Vit. D3 Tablets IP | Batch SNT-250038Mfg Feb 2026 · Exp Jan 2028 | The sample does not conforms to claim as per IP 2022 in respect to the test of Dissolution of calcium and Assay of Vit.D3 Claim 250 i.u Found 179.15 IUAssay | DTL-BaddiState lab | Aug 2026 |
| Cefixime Tablets IP 200 mg | Batch DL-134Mfg Oct 2024 · Exp Nov 2026 | AssayAssay | RDTL, ChandigarhCDSCO lab | Sep 2025 |
| Amoxycillin Trihydrate Dispersible Tablets IP 250 mg | Batch DL-58Mfg Oct 2024 · Exp Sep 2026 | Disintegration test, Uniformity of dispersion and AssayAssay | RDTL, ChandigarhCDSCO lab | Sep 2025 |
| Omeford - 40 | Batch SNT-220421Mfg Sep 2022 · Exp Aug 2024 | THE CONTENT OF OMEPRAZOLE IN THE SAMPLE IS LESS (l.e. 40.84% OF LABELLED AMOUNT) THAN THE SCHEDULE V LIMITSLabelling | State Lab MaharashtraState lab | Jun 2024 |
| CEFUROXIME AXETIL TABLETS I.P. (AXTUM-250) | Batch SBT-16732Mfg Dec 2017 · Exp Nov 2019 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.